Staphylococcus aureus Bakteriämie: Unterschied zwischen den Versionen

So steigt das Risiko für Komplikationen bei Vorliegen von: <ul><li>Herzklappenersatz um 5-10%</li><li>Herzschrittmachern um 27-37%</li><li>Gelenkersatz um 29-39%</li><li>Osteosynthesematerial 7%</li><li> tiefsitzender primärer Fokus</li><li>positive Folgeblutkulturen nach 2-4 Tage nach initialer Blutkultur</li><li>keine Entfieberung innerhalb von 72 Stunden nach Therapiebeginn</li></ul><ref>OBEID, K.M., SZPUNAR, S. and KHATIB, R. (2012), Long-Term Outcomes of Cardiovascular Implantable Electronic Devices in Patients with Staphylococcus aureus Bacteremia. Pacing and Clinical Electrophysiology, 35: 961-965. https://doi.org/10.1111/j.1540-8159.2012.03438.x</ref><ref>Chamis AL, Peterson GE, Cabell CH, Corey GR, Sorrentino RA, Greenfield RA, Ryan T, Reller LB, Fowler VG Jr. Staphylococcus aureus bacteremia in patients with permanent pacemakers or implantable cardioverter-defibrillators. Circulation. 2001 Aug 28;104(9):1029-33. doi: 10.1161/hc3401.095097. PMID: 11524397.</ref><ref>David R. Murdoch, Sally A. Roberts, Vance G. Fowler, Jr., Manish A. Shah, Susan L. Taylor, Arthur J. Morris, G. Ralph Corey, Infection of Orthopedic Prostheses after Staphylococcus aureus Bacteremia, Clinical Infectious Diseases, Volume 32, Issue 4, 15 February 2001, Pages 647–649, https://doi.org/10.1086/318704</ref><ref>Lalani T, Chu VH, Grussemeyer CA, Reed SD, Bolognesi MP, Friedman JY, Griffiths RI, Crosslin DR, Kanafani ZA, Kaye KS, Ralph Corey G, Fowler VG Jr. Clinical outcomes and costs among patients with Staphylococcus aureus bacteremia and orthopedic device infections. Scand J Infect Dis. 2008;40(11-12):973-7. doi: 10.1080/00365540802245146. PMID: 18615359.</ref><ref>Sendi P, Banderet F, Graber P, Zimmerli W. Periprosthetic joint infection following Staphylococcus aureus bacteremia. J Infect. 2011 Jul;63(1):17-22. doi: 10.1016/j.jinf.2011.05.005. Epub 2011 May 14. PMID: 21663971.</ref>

==Hinweise zur Therapie==